SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 31
Posts 2,481
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/17/2017 11:54:01 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:35:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/25/2017 5:12:52 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:26:07 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/17/2017 3:36:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/7/2017 2:33:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2017 5:17:05 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 5:28:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 3/24/2017 4:38:38 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 3/24/2017 4:32:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/23/2017 5:02:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/23/2017 5:00:30 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 3/22/2017 10:02:26 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/10/2017 8:11:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/7/2017 3:20:30 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/10/2017 10:09:15 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/8/2017 11:25:24 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/6/2017 2:47:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/23/2017 9:23:13 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/19/2017 4:58:32 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 1/10/2017 5:02:42 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/10/2017 5:01:52 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/30/2016 6:08:08 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/29/2016 4:31:56 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/29/2016 11:40:59 AM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 119235 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist